Professor Rabii Madi with the Sonablate machine. Pawan Singh / The National
Professor Rabii Madi with the Sonablate machine. Pawan Singh / The National
Professor Rabii Madi with the Sonablate machine. Pawan Singh / The National
Professor Rabii Madi with the Sonablate machine. Pawan Singh / The National

Non-invasive prostate cancer-killing ultrasound therapy to begin in Dubai


Nick Webster
  • English
  • Arabic

A high-frequency ultrasound to kill off prostate cancer is to be used in Dubai for the first time in a move that will pave the way for less invasive treatments.

The high-intensity focused ultrasound (HIFU) is to be delivered to a select group of men, whose symptoms and medical profile make them more suitable for the alternative treatment than surgery or radiation therapy.

Prostate cancer can be difficult to treat, with often no symptoms in their early stages leaving some patients facing few alternatives to traditional treatment methods once the cancer has progressed.

Common side effects after prostate removal include incontinence and erectile dysfunction, while radiation treatment can bring fatigue, as well as bowel and bladder problems.

It is difficult to get rid of the cancer completely without surgically removing the prostate, usually by robotic-assisted laparoscopy
Dr Rishikesh Pandya,
consultant uro-oncologist at Burjeel Medical City

High-frequency sound waves delivered by the $600,000 machine will precisely target and destroy cancerous tissue offering fewer side effects, better quality of life and faster recovery, experts said.

Although expensive, the treatment is due to be given to the first patients this month, at the Clemenceau Medical Centre Hospital in Dubai.

Professor Rabii Madi, a consultant urologist and expert in robotic surgery at CMC in Zabeel, said the treatment will become more widely available in the future.

“We are the first in the Arab world to launch this (Sonablate) treatment, so it’s very new here,” he said.

“The Sonablate machine will focus the ultrasound waves to target prostate cancer cells.

“This is used for patients with localised prostate cancer, and can only be used in men in a low-risk group or intermediate-risk group.

“Not every man with prostate cancer is a candidate, so it is my job to select patients who qualify.”

Precision therapy

The same precision therapy is already used in about 60 nations, with a similar Focal One High-Intensity Focused Ultrasound (HIFU) treatment for prostate cancer introduced at the Cleveland Clinic Abu Dhabi earlier this year.

A long-term study of outcomes on men who used the therapy was published in 2022 in the journal of European Urology.

The health of 1,379 men in the UK with an average age of 66 who used the HIFU therapy was checked for at least five years post-treatment.

Failure-free survival – the definition used by medics to assess how successful treatment has been with no further evidence of disease or therapies – was seen in 68 per cent of patients, seven years after HIFU was delivered.

“In terms of cancer control, HIFU is comparable in outcomes and cost to surgery and radiation, at least based on the studies done to date,” said Dr Madi, who hopes the treatment will eventually be routinely covered by insurance.

“But of course, it is not for every man as some patients will have aggressive cancers.

“We have had training in the UK and also a team from the US has visited to train other staff and nurses. Hopefully, we will have the first case in the UAE at the end of June.”

Prostate cancer is the most common form of the disease in men, affecting about one in eight adult males and twice that number in men of African descent.

According to the WHO’s Global Cancer Observatory, prostate cancer accounts for 11.9 per cent of all cancer in UAE men – the second most common form of the disease in the country, behind colorectal cancer (13.3 per cent).

Professor Rabii Madi at the Dubai Clemenceau Medical Centre Hospital in Dubai. Pawan Singh / The National
Professor Rabii Madi at the Dubai Clemenceau Medical Centre Hospital in Dubai. Pawan Singh / The National

Survival rates

While survival rates are high, prostate cancer can be difficult to detect in its early stages with few or even no symptoms.

This can delay treatment, increasing the risk of cancer developing further and the need for more aggressive therapy.

Dr Rishikesh Pandya, is a consultant uro-oncologist at Burjeel Medical City where robotic surgery is used to treat men.

“It is difficult to get rid of the cancer completely without surgically removing the prostate, usually by robotic-assisted laparoscopy,” he said.

“We tend to use robotic surgery in younger males, and radiation for older patients.

“This kind of surgery gets rid of the cancer, without damaging sexual function by saving the nerves which can be impacted.

“HIFU has been studied and evaluated over years in comparison to mainstream treatments and surgery.

“It is not yet offered as a primary line of treatment, as there is a chance of resurgence of the cancer which would then also need surgery or radiation.”

The most common test for prostate cancer is a PSA blood test in men over 40, which measures antigens that could signal abnormalities.

A reading above 2.5 ng/ml is considered abnormal and would usually lead to follow-up tests, a biopsy or an MRI scan to confirm a diagnosis.

However, about 10-12 per cent of men will receive a false positive, leading some to have further, unnecessary invasive tests.

Spit test

Research is under way into how a simple spit test could provide a more effective, cheaper alternative to a PSA.

DNA extracted from saliva – called a polygenic risk score – was found to be a better tool for accurately detecting prostate cancer by The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust.

Further tests are under way in 300,000 men in Britain to see how the test could be more widely used in those with the highest genetic risk.

“These saliva tests are done with random genetic material profiling,” said Dr Pandya.

“They are still under clinical trials and not yet recommended under any other guidelines for cancer diagnosis anywhere in the world.

“If there is a strong family history of prostate cancer, these kinds of tests are suitable, but a PSA test can be done in anyone over the age of 50.”

Specs

Engine: Dual-motor all-wheel-drive electric

Range: Up to 610km

Power: 905hp

Torque: 985Nm

Price: From Dh439,000

Available: Now

MATCH INFO

Fulham 0

Aston Villa 3 (Grealish 4', Hourihane 15', Mings 48')

Man of the match: Jack Grealish (Aston Villa)

The specs: 2019 Cadillac XT4

Price, base: Dh145,000

Engine: 2.0-litre turbocharged in-line four-cylinder engine

Transmission: Nine-speed automatic

Power: 237hp @ 5,000rpm

Torque: 350Nm @ 1,500rpm

Fuel economy, combined: 8.7L / 100km

How to help

Send “thenational” to the following numbers or call the hotline on: 0502955999
2289 – Dh10
2252 – Dh 50
6025 – Dh20
6027 – Dh 100
6026 – Dh 200

The White Lotus: Season three

Creator: Mike White

Starring: Walton Goggins, Jason Isaacs, Natasha Rothwell

Rating: 4.5/5

Grand Slam Los Angeles results

Men:
56kg – Jorge Nakamura
62kg – Joao Gabriel de Sousa
69kg – Gianni Grippo
77kg – Caio Soares
85kg – Manuel Ribamar
94kg – Gustavo Batista
110kg – Erberth Santos

Women:
49kg – Mayssa Bastos
55kg – Nathalie Ribeiro
62kg – Gabrielle McComb
70kg – Thamara Silva
90kg – Gabrieli Pessanha

COMPANY%20PROFILE
%3Cp%3E%3Cstrong%3EName%3A%3C%2Fstrong%3E%20Carzaty%2C%20now%20Kavak%3Cbr%3E%3Cstrong%3EBased%3A%3C%2Fstrong%3E%20Dubai%3Cbr%3E%3Cstrong%3ELaunch%20year%3A%20%3C%2Fstrong%3ECarzaty%20launched%20in%202018%2C%20Kavak%20in%20the%20GCC%20launched%20in%202022%3Cbr%3E%3Cstrong%3ENumber%20of%20employees%3A%3C%2Fstrong%3E%20140%3Cbr%3E%3Cstrong%3ESector%3A%3C%2Fstrong%3E%20Automotive%3Cbr%3E%3Cstrong%3EFunding%3A%20%3C%2Fstrong%3ECarzaty%20raised%20%246m%20in%20equity%20and%20%244m%20in%20debt%3B%20Kavak%20plans%20%24130m%20investment%20in%20the%20GCC%3C%2Fp%3E%0A
COMPANY%20PROFILE
%3Cp%3E%3Cstrong%3ECompany%20name%3A%3C%2Fstrong%3E%20The%20Cloud%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3EStarted%3A%3C%2Fstrong%3E%202018%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3EFounders%3A%3C%2Fstrong%3E%20George%20Karam%20and%20Kamil%20Rogalinski%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3EBased%3A%3C%2Fstrong%3E%20Hub71%2C%20Abu%20Dhabi%2C%20UAE%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3EIndustry%3A%3C%2Fstrong%3E%20Food%20technology%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3EFunding%20size%3A%3C%2Fstrong%3E%20%2410m%2B%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3EInvestors%3A%3C%2Fstrong%3E%20Middle%20East%20Venture%20Partners%2C%20Olayan%20Financing%2C%20Rua%20Growth%20Fund%3C%2Fp%3E%0A
UK-EU trade at a glance

EU fishing vessels guaranteed access to UK waters for 12 years

Co-operation on security initiatives and procurement of defence products

Youth experience scheme to work, study or volunteer in UK and EU countries

Smoother border management with use of e-gates

Cutting red tape on import and export of food

RESULT

West Brom 2 Liverpool 2
West Brom: Livermore (79'), Rondón (88' ) 
Liverpool: Ings (4'), Salah (72') 

Last 10 NBA champions

2017: Golden State bt Cleveland 4-1
2016: Cleveland bt Golden State 4-3
2015: Golden State bt Cleveland 4-2
2014: San Antonio bt Miami 4-1
2013: Miami bt San Antonio 4-3
2012: Miami bt Oklahoma City 4-1
2011: Dallas bt Miami 4-2
2010: Los Angeles Lakers bt Boston 4-3
2009: Los Angeles Lakers bt Orlando 4-1
2008: Boston bt Los Angeles Lakers 4-2

Springsteen: Deliver Me from Nowhere

Director: Scott Cooper

Starring: Jeremy Allen White, Odessa Young, Jeremy Strong

Rating: 4/5

Mercer, the investment consulting arm of US services company Marsh & McLennan, expects its wealth division to at least double its assets under management (AUM) in the Middle East as wealth in the region continues to grow despite economic headwinds, a company official said.

Mercer Wealth, which globally has $160 billion in AUM, plans to boost its AUM in the region to $2-$3bn in the next 2-3 years from the present $1bn, said Yasir AbuShaban, a Dubai-based principal with Mercer Wealth.

Within the next two to three years, we are looking at reaching $2 to $3 billion as a conservative estimate and we do see an opportunity to do so,” said Mr AbuShaban.

Mercer does not directly make investments, but allocates clients’ money they have discretion to, to professional asset managers. They also provide advice to clients.

“We have buying power. We can negotiate on their (client’s) behalf with asset managers to provide them lower fees than they otherwise would have to get on their own,” he added.

Mercer Wealth’s clients include sovereign wealth funds, family offices, and insurance companies among others.

From its office in Dubai, Mercer also looks after Africa, India and Turkey, where they also see opportunity for growth.

Wealth creation in Middle East and Africa (MEA) grew 8.5 per cent to $8.1 trillion last year from $7.5tn in 2015, higher than last year’s global average of 6 per cent and the second-highest growth in a region after Asia-Pacific which grew 9.9 per cent, according to consultancy Boston Consulting Group (BCG). In the region, where wealth grew just 1.9 per cent in 2015 compared with 2014, a pickup in oil prices has helped in wealth generation.

BCG is forecasting MEA wealth will rise to $12tn by 2021, growing at an annual average of 8 per cent.

Drivers of wealth generation in the region will be split evenly between new wealth creation and growth of performance of existing assets, according to BCG.

Another general trend in the region is clients’ looking for a comprehensive approach to investing, according to Mr AbuShaban.

“Institutional investors or some of the families are seeing a slowdown in the available capital they have to invest and in that sense they are looking at optimizing the way they manage their portfolios and making sure they are not investing haphazardly and different parts of their investment are working together,” said Mr AbuShaban.

Some clients also have a higher appetite for risk, given the low interest-rate environment that does not provide enough yield for some institutional investors. These clients are keen to invest in illiquid assets, such as private equity and infrastructure.

“What we have seen is a desire for higher returns in what has been a low-return environment specifically in various fixed income or bonds,” he said.

“In this environment, we have seen a de facto increase in the risk that clients are taking in things like illiquid investments, private equity investments, infrastructure and private debt, those kind of investments were higher illiquidity results in incrementally higher returns.”

The Abu Dhabi Investment Authority, one of the largest sovereign wealth funds, said in its 2016 report that has gradually increased its exposure in direct private equity and private credit transactions, mainly in Asian markets and especially in China and India. The authority’s private equity department focused on structured equities owing to “their defensive characteristics.”

Russia's Muslim Heartlands

Dominic Rubin, Oxford

UK’s AI plan
  • AI ambassadors such as MIT economist Simon Johnson, Monzo cofounder Tom Blomfield and Google DeepMind’s Raia Hadsell
  • £10bn AI growth zone in South Wales to create 5,000 jobs
  • £100m of government support for startups building AI hardware products
  • £250m to train new AI models
Updated: June 12, 2024, 11:28 AM